About this trial
Knee is the most common site of osteoarthritis. Treatment of knee osteoarthritis starts with a full course of medical therapy, followed by surgery to replace the knee with a prosthesis if this strategy fails, or in advanced cases. However, the new recommendations of the French rheumatology society, which evaluate the various treatments and position them in the treatment plan, are not well known, and the definition of a complete treatment remains unclear. The vast majority of patients are therefore referred to a surgeon after having tried a small part of the therapeutic arsenal (generally analgesics and corticosteroid or hyaluronic acid infiltrations). The goal of this study is to to select patients most likely to gain from surgery and to develop strategies that avoid the need for major surgery.
Eligibility criteria
Qualifiers
Age 18-90 years old
Femoro-tibial osteoarthritis Kellgren stage stage≥ 2 without laxity in extension;
A proposal of total knee replacement by a surgeon;
No corticosteroid joint injection within 3 months;
Disqualifiers
Contraindication or no indication to surgery or medical care (severe infection for example)
Inflammatory arthritis
Lack of social insurance
Symptomatic (VAS pain >40) contralateral knee or hip osteoarthritis (with or without replacement)
Trial design
Treatments tested in this trial
- arthroplasty
- Medical and non-medical treatments